Iridex Corp (NASDAQ: IRIX) reported Q2 EPS of ($0.03), $0.04 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.9 million.

Guidance: The Company continues to expect revenue growth for the full year 2016 to be in the low double-digits, with higher revenue in the fourth quarter relative to the third quarter due to typical seasonality. For the third quarter of 2016, the Company anticipates revenues of $11.0 million to $11.3 million.

For earnings history and earnings-related data on Iridex Corp (IRIX) click here.